A murine model of acute myeloid leukemia with Evi1 overexpression and autocrine stimulation by an intracellular form of GM-CSF in DA-3 cells

References

• Appelbaum FR, Gundacker H, Head DR, et al. Age and acute myeloid leukemia. Blood 2006;107:3481–3485.
   PubMed Web of Science ®Google Scholar
• Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009;114:937–951.
   PubMed Web of Science ®Google Scholar
• Marcucci G, Haferlach T, Dohner H. Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications. J Clin Oncol 2011;29:475–486.
   PubMed Web of Science ®Google Scholar
• Mucenski ML, Taylor BA, Ihle JN, et al. Identification of a common ecotropic viral integration site, Evi-1, in the DNA of AKXD murine myeloid tumors. Mol Cell Biol 1988;8:301–308.
   PubMed Web of Science ®Google Scholar
• Ihle JN, Askew D. Origins and properties of hematopoietic growth factor-dependent cell lines. Int J Cell Cloning 1989;7:68–91.
   PubMedGoogle Scholar
• Lugthart S, van Drunen E, van Norden Y, et al. High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated. Blood 2008;111:4329–4337.
   PubMed Web of Science ®Google Scholar
• Barjesteh van Waalwijk van Doorn-Khosrovani S, Erpelinck C, van Putten WL, et al. High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients. Blood 2003;101:837–845.
   PubMed Web of Science ®Google Scholar
• Santamaria CM, Chillon MC, Garcia-Sanz R, et al. Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia. Blood 2009;114:148–152.
   PubMed Web of Science ®Google Scholar
• Vazquez I, Maicas M, Cervera J, et al. Down-regulation of EVI1 is associated with epigenetic alterations and good prognosis in patients with acute myeloid leukemia. Haematologica 2011;96:1448–1456.
   PubMed Web of Science ®Google Scholar
• Groschel S, Lugthart S, Schlenk RF, et al. High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities. J Clin Oncol 2010;28:2101–2107.
   PubMed Web of Science ®Google Scholar
• Haas K, Kundi M, Sperr WR, et al. Expression and prognostic significance of different mRNA 5’-end variants of the oncogene EVI1 in 266 patients with de novo AML: EVI1 and MDS1/EVI1 overexpression both predict short remission duration. Genes Chromosomes Cancer 2008;47:288–298.
   PubMed Web of Science ®Google Scholar
• Ohyashiki JH, Ohyashiki K, Shimamoto T, et al. Ecotropic virus integration site-1 gene preferentially expressed in post-myelodysplasia acute myeloid leukemia: possible association with GATA-1, GATA-2, and stem cell leukemia gene expression. Blood 1995;85:3713–3718.
   PubMed Web of Science ®Google Scholar
• Daghistani M, Marin D, Khorashad JS, et al. EVI-1 oncogene expression predicts survival in chronic-phase CML patients resistant to imatinib treated with second-generation tyrosine kinase inhibitors. Blood 2010;116:6014–6017.
   PubMed Web of Science ®Google Scholar
• Morishita K, Parker DS, Mucenski ML, et al. Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines. Cell 1988;54:831–840.
   PubMed Web of Science ®Google Scholar
• Hoyt PR, Bartholomew C, Davis AJ, et al. The Evi1 proto-oncogene is required at midgestation for neural, heart, and paraxial mesenchyme development. Mech Dev 1997;65:55–70.
   PubMed Web of Science ®Google Scholar
• Perkins AS, Mercer JA, Jenkins NA, et al. Patterns of Evi-1 expression in embryonic and adult tissues suggest that Evi-1 plays an important regulatory role in mouse development. Development 1991;111:479–487.
   PubMed Web of Science ®Google Scholar
• Yuasa H, Oike Y, Iwama A, et al. Oncogenic transcription factor Evi1 regulates hematopoietic stem cell proliferation through GATA-2 expression. Embo J 2005;24:1976–1987.
   PubMed Web of Science ®Google Scholar
• Kurokawa M, Mitani K, Irie K, et al. The oncoprotein Evi-1 represses TGF-beta signalling by inhibiting Smad3. Nature 1998;394:92–96.
   PubMed Web of Science ®Google Scholar
• Glass C, Wuertzer C, Cui X, et al. Global identification of EVI1 target genes in acute myeloid leukemia. PLoS One 2013;8:e67134.
   PubMed Web of Science ®Google Scholar
• Morishita K, Parganas E, Matsugi T, et al. Expression of the Evi-1 zinc finger gene in 32Dc13 myeloid cells blocks granulocytic differentiation in response to granulocyte colony-stimulating factor. Mol Cell Biol 1992;12:183–189.
   PubMed Web of Science ®Google Scholar
• Liu Y, Chen L, Ko TC, et al. Evi1 is a survival factor which conveys resistance to both TGFbeta- and taxol-mediated cell death via PI3K/AKT. Oncogene 2006;25:3565–3575.
   PubMed Web of Science ®Google Scholar
• Chi Y, Senyuk V, Chakraborty S, et al. EVI1 promotes cell proliferation by interacting with BRG1 and blocking the repression of BRG1 on E2F1 activity. J Biol Chem 2003;278:49806–49811.
   PubMed Web of Science ®Google Scholar
• Karakaya K, Herbst F, Ball C, et al. Overexpression of EVI1 interferes with cytokinesis and leads to accumulation of cells with supernumerary centrosomes in G0/1 phase. Cell Cycle 2012;11:3492–3503.
   PubMed Web of Science ®Google Scholar
• Kustikova O, Fehse B, Modlich U, et al. Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking. Science 2005;308:1171–1174.
   PubMed Web of Science ®Google Scholar
• Modlich U, Navarro S, Zychlinski D, et al. Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors. Mol Ther 2009;17:1919–1928.
   PubMed Web of Science ®Google Scholar
• Stein S, Ott MG, Schultze-Strasser S, et al. Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease. Nat Med 2010;16:198–204.
   PubMed Web of Science ®Google Scholar
• Glass C, Wilson M, Gonzalez R, et al. The role of EVI1 in myeloid malignancies. Blood Cells Mol Dis 2014;53:67–76.
   PubMed Web of Science ®Google Scholar
• Bartholomew C, Morishita K, Askew D, et al. Retroviral insertions in the CB-1/Fim-3 common site of integration activate expression of the Evi-1 gene. Oncogene 1989;4:529–534.
   PubMed Web of Science ®Google Scholar
• Holmes KL, Palaszynski E, Fredrickson TN, et al. Correlation of cell-surface phenotype with the establishment of interleukin 3-dependent cell lines from wild-mouse murine leukemia virus-induced neoplasms. Proc Natl Acad Sci U S A 1985;82:6687–6691.
   PubMed Web of Science ®Google Scholar
• Ihle JN, Rein A, Mural R. Immunologic and virologic mechanisms in retrovirus-induced murine leukemogenesis. In: Klein G, editor. Advances in viral oncology. New York: Raven Press; 1984. pp 95–137.
   Google Scholar
• Arteaga HJ, Mohamed AJ, Christensson B, et al. Genetically modified autoactivated cells expressing intracellular forms of GM-CSF as a model for regulated administration of cytokines. Scand J Immunol 2005;62:429–436.
   PubMed Web of Science ®Google Scholar
• Kogan SC, Ward JM, Anver MR, et al.Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice. Blood 2002;100:238–245.
   PubMed Web of Science ®Google Scholar
• Isfort RJ, Ihle JN. Multiple hematopoietic growth factors signal through tyrosine phosphorylation. Growth Factors 1990;2:213–220.
   PubMedGoogle Scholar
• Lundin KE, Ge R, Svahn MG, et al. Cooperative strand invasion of supercoiled plasmid DNA by mixed linear PNA and PNA-peptide chimeras. Biomol Eng 2004;21:51–59.
   PubMedGoogle Scholar
• Heinonen JE, Mohamed AJ, Nore BF, et al. Inducible H1 promoter-driven lentiviral siRNA expression by Stuffer reporter deletion. Oligonucleotides 2005;15:139–144.
   PubMed Web of Science ®Google Scholar
• Schefe JH, Lehmann KE, Buschmann IR, et al. Quantitative real-time RT-PCR data analysis: current concepts and the novel “gene expression's CT difference” formula. J Mol Med (Berl) 2006;84: 901–910.
   PubMed Web of Science ®Google Scholar
• Ramakers C, Ruijter JM, Deprez RH, et al. Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci Lett 2003;339:62–66.
   PubMed Web of Science ®Google Scholar
• Alzuherri H, McGilvray R, Kilbey A, et al. Conservation and expression of a novel alternatively spliced Evi1 exon. Gene 2006; 384:154–162.
   PubMed Web of Science ®Google Scholar
• Bartholomew C, Ihle JN. Retroviral insertions 90 kilobases proximal to the Evi-1 myeloid transforming gene activate transcription from the normal promoter. Mol Cell Biol 1991;11:1820–1828.
   PubMed Web of Science ®Google Scholar
• Matsugi T, Morishita K, Ihle JN. Identification, nuclear localization, and DNA-binding activity of the zinc finger protein encoded by the Evi-1 myeloid transforming gene. Mol Cell Biol 1990;10: 1259–1264.
   PubMed Web of Science ®Google Scholar
• McGilvray R, Walker M, Bartholomew C. UXT interacts with the transcriptional repressor protein EVI1 and suppresses cell transformation. FEBS J 2007;274:3960–3971.
   PubMed Web of Science ®Google Scholar
• Lee JC, Ihle JN. Increased responses to lymphokines are correlated with preleukemia in mice inoculated with Moloney leukemia virus. Proc Natl Acad Sci U S A 1981;78:7712–7716.
   PubMed Web of Science ®Google Scholar
• Asou H, Suzukawa K, Kita K, et al. Establishment of an undifferentiated leukemia cell line (Kasumi-3) with t(3;7)(q27;q22) and activation of the EVI1 gene. Jpn J Cancer Res 1996;87:269–274.
   PubMedGoogle Scholar
• Oval J, Smedsrud M, Taetle R. Expression and regulation of the Evi-1 gene in the human factor-dependent leukemia cell line, UCSD/AML1. Leukemia 1992;6:446–451.
   PubMed Web of Science ®Google Scholar
• Jahns-Streubel G, Braess J, Schoch C, et al. Cytogenetic subgroups in acute myeloid leukemia differ in proliferative activity and response to GM-CSF. Leukemia 2001;15:377–384.
   PubMed Web of Science ®Google Scholar
• Metcalf D. Role of hemopoietic growth factors in the development and suppression of myeloid leukemia. Leukemia 1992;6(Suppl. 3):187S–188S.
   PubMedGoogle Scholar
• Tsuzuki M, Ezaki K, Maruyama F, et al. Proliferative effects of several hematopoietic growth factors on acute myelogenous leukemia cells and correlation with treatment outcome. Leukemia 1997; 11:2125–2130.
   PubMed Web of Science ®Google Scholar
• Oster W, Lindemann A, Ganser A, et al. Constitutive expression of hematopoietic growth factor genes by acute myeloblastic leukemia cells. Behring Inst Mitt 1988:68–79.
   Google Scholar
• Young DC, Wagner K, Griffin JD. Constitutive expression of the granulocyte-macrophage colony-stimulating factor gene in acute myeloblastic leukemia. J Clin Invest 1987;79:100–106.
   PubMed Web of Science ®Google Scholar
• Perkins A, Kongsuwan K, Visvader J, et al. Homeobox gene expression plus autocrine growth factor production elicits myeloid leukemia. Proc Natl Acad Sci U S A 1990;87:8398–8402.
   PubMed Web of Science ®Google Scholar
• Palmqvist L, Argiropoulos B, Pineault N, et al. The Flt3 receptor tyrosine kinase collaborates with NUP98-HOX fusions in acute myeloid leukemia. Blood 2006;108:1030–1036.
   PubMed Web of Science ®Google Scholar
• Arteaga HJ, Mohamed AJ, Christensson B, et al. Expression and release of stable and active forms of murine granulocyte-macrophage colony-stimulating factor (mGM-CSF) targeted to different subcellular compartments. Cytokine 2001;14:136–142.
   PubMed Web of Science ®Google Scholar
• Trapnell BC, Whitsett JA. Gm-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense. Annu Rev Physiol 2002;64:775–802.
   PubMed Web of Science ®Google Scholar
• Shimizu S, Nagasawa T, Katoh O, et al. EVI1 is expressed in megakaryocyte cell lineage and enforced expression of EVI1 in UT-7/GM cells induces megakaryocyte differentiation. Biochem Biophys Res Commun 2002;292:609–616.
   PubMed Web of Science ®Google Scholar
• Laricchia-Robbio L, Nucifora G. Significant increase of self-renewal in hematopoietic cells after forced expression of EVI1. Blood Cells Mol Dis 2008;40:141–147.
   PubMed Web of Science ®Google Scholar
• Pepersack L, Lee JC, McEwan R, Ihle JN. Phenotypic heterogeneity of Moloney leukemia virus-induced T cel lymphomas. J Immunol 1980;124:279–285.
   PubMed Web of Science ®Google Scholar
• Li Z, Dullmann J, Schiedlmeier B, et al. Murine leukemia induced by retroviral gene marking. Science 2002;296:497.
   PubMed Web of Science ®Google Scholar
• Modlich U, Schambach A, Brugman MH, et al. Leukemia induction after a single retroviral vector insertion in Evi1 or Prdm16. Leukemia 2008;22:1519–1528.
   PubMed Web of Science ®Google Scholar
• Goyama S, Kurokawa M. Evi-1 as a critical regulator of leukemic cells. Int J Hematol 2010;91:753–757.
   PubMed Web of Science ®Google Scholar
• McCormack E, Bruserud O, Gjertsen BT. Animal models of acute myelogenous leukaemia – development, application and future perspectives. Leukemia 2005;19:687–706.
   PubMed Web of Science ®Google Scholar